CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Pleural Dynamics Announces Completion of Enrollment of “The ACES Study for Aseptic Pleural Effusions,” a Post Market Study Evaluating the Novel ACES Automatic Continuous Effusion Shunt System

leural Dynamics’ innovative, fully implantable, patient motion powered shunt offers [...]

By |2025-08-19T16:41:22+00:00August 19, 2025|3rd Party Medical Device Industry News|Comments Off on Pleural Dynamics Announces Completion of Enrollment of “The ACES Study for Aseptic Pleural Effusions,” a Post Market Study Evaluating the Novel ACES Automatic Continuous Effusion Shunt System

New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease | Presented at the 2025 Alzheimer’s Association International Conference

Demonstrates that the VeraBIND Tau assay accurately measures active tau [...]

By |2025-07-28T14:40:14+00:00July 28, 2025|3rd Party Medical Device Industry News|Comments Off on New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease | Presented at the 2025 Alzheimer’s Association International Conference

Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer

The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]

By |2025-06-13T17:14:05+00:00June 13, 2025|3rd Party Medical Device Industry News|Comments Off on Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
Go to Top